BRAF V600E Mutation Positive
5 clinical trials · Condition
◉ Watch BRAF V600E Mutation Positive
| Record | Firm | Date |
|---|---|---|
| Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers (NCT04462471) | Memorial Sloan Kettering Cancer Center | 2020-06-26 |
| A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) (NCT04317599) | Pierre Fabre Medicament | 2020-04-12 |
Track BRAF V600E Mutation Positive automatically
Every clearance here is in the API, with alerts when new ones post.